TRVI logo

Trevi Therapeutics, Inc. (TRVI) Free cash flow

annual FCF:

-$38.29M-$6.44M(-20.23%)
December 31, 2024

Summary

  • As of today (September 16, 2025), TRVI annual free cash flow is -$38.29 million, with the most recent change of -$6.44 million (-20.23%) on December 31, 2024.
  • During the last 3 years, TRVI annual FCF has fallen by -$9.35 million (-32.28%).
  • TRVI annual FCF is now -242.13% below its all-time high of -$11.19 million, reached on December 1, 2016.

Performance

TRVI Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIcash flow metrics

quarterly FCF:

-$10.10M+$3.38M(+25.05%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TRVI quarterly free cash flow is -$10.10 million, with the most recent change of +$3.38 million (+25.05%) on June 30, 2025.
  • Over the past year, TRVI quarterly FCF has dropped by -$1.39 million (-15.96%).
  • TRVI quarterly FCF is now -146.07% below its all-time high of -$4.11 million, reached on March 31, 2019.

Performance

TRVI quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIcash flow metrics

TTM FCF:

-$42.69M-$1.39M(-3.37%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TRVI TTM free cash flow is -$42.69 million, with the most recent change of -$1.39 million (-3.37%) on June 30, 2025.
  • Over the past year, TRVI TTM FCF has dropped by -$9.84 million (-29.93%).
  • TRVI TTM FCF is now -659.63% below its all-time high of -$5.62 million, reached on June 30, 2018.

Performance

TRVI TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

TRVI Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-20.2%-16.0%-29.9%
3 y3 years-32.3%-63.5%-59.7%
5 y5 years-65.8%-19.6%-57.8%

TRVI Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-35.1%at low-63.5%+25.1%-59.7%at low
5 y5-year-65.8%at low-63.5%+25.1%-62.3%at low
alltimeall time-242.1%at low-146.1%+25.1%-659.6%at low

TRVI Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$10.10M(-25.1%)
-$42.69M(+3.4%)
Mar 2025
-
-$13.48M(+41.0%)
-$41.30M(+7.9%)
Dec 2024
-$38.29M(+20.2%)
-$9.56M(+0.0%)
-$38.29M(+9.0%)
Sep 2024
-
-$9.56M(+9.7%)
-$35.12M(+6.9%)
Jun 2024
-
-$8.71M(-16.8%)
-$32.86M(-3.5%)
Mar 2024
-
-$10.47M(+64.0%)
-$34.06M(+6.9%)
Dec 2023
-$31.85M(+12.4%)
-$6.38M(-12.6%)
-$31.85M(-0.2%)
Sep 2023
-
-$7.30M(-26.4%)
-$31.91M(-4.0%)
Jun 2023
-
-$9.91M(+20.1%)
-$33.23M(+12.7%)
Mar 2023
-
-$8.25M(+28.0%)
-$29.50M(+4.1%)
Dec 2022
-$28.33M(-2.1%)
-$6.45M(-25.2%)
-$28.33M(+0.8%)
Sep 2022
-
-$8.62M(+39.6%)
-$28.12M(+5.2%)
Jun 2022
-
-$6.18M(-12.9%)
-$26.74M(-6.1%)
Mar 2022
-
-$7.09M(+13.9%)
-$28.46M(-1.7%)
DateAnnualQuarterlyTTM
Dec 2021
-$28.95M(-0.3%)
-$6.23M(-14.0%)
-$28.95M(-8.5%)
Sep 2021
-
-$7.24M(-8.3%)
-$31.65M(+0.8%)
Jun 2021
-
-$7.90M(+4.2%)
-$31.39M(-1.7%)
Mar 2021
-
-$7.58M(-15.1%)
-$31.94M(+10.0%)
Dec 2020
-$29.03M(+25.7%)
-$8.93M(+27.9%)
-$29.03M(+10.4%)
Sep 2020
-
-$6.98M(-17.4%)
-$26.30M(-2.8%)
Jun 2020
-
-$8.45M(+80.8%)
-$27.06M(+14.3%)
Mar 2020
-
-$4.67M(-24.7%)
-$23.67M(+2.5%)
Dec 2019
-$23.10M(+25.0%)
-$6.20M(-19.8%)
-$23.10M(+6.3%)
Sep 2019
-
-$7.73M(+52.8%)
-$21.72M(+55.3%)
Jun 2019
-
-$5.06M(+23.3%)
-$13.99M(-3.8%)
Mar 2019
-
-$4.11M(-14.9%)
-$14.55M(+39.3%)
Dec 2018
-$18.48M(+65.1%)
-$4.82M(-14.2%)
-$10.44M(+85.8%)
Jun 2018
-
-$5.62M
-$5.62M
Dec 2016
-$11.19M
-
-

FAQ

  • What is Trevi Therapeutics, Inc. annual free cash flow?
  • What is the all time high annual FCF for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. annual FCF year-on-year change?
  • What is Trevi Therapeutics, Inc. quarterly free cash flow?
  • What is the all time high quarterly FCF for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. quarterly FCF year-on-year change?
  • What is Trevi Therapeutics, Inc. TTM free cash flow?
  • What is the all time high TTM FCF for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. TTM FCF year-on-year change?

What is Trevi Therapeutics, Inc. annual free cash flow?

The current annual FCF of TRVI is -$38.29M

What is the all time high annual FCF for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high annual free cash flow is -$11.19M

What is Trevi Therapeutics, Inc. annual FCF year-on-year change?

Over the past year, TRVI annual free cash flow has changed by -$6.44M (-20.23%)

What is Trevi Therapeutics, Inc. quarterly free cash flow?

The current quarterly FCF of TRVI is -$10.10M

What is the all time high quarterly FCF for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high quarterly free cash flow is -$4.11M

What is Trevi Therapeutics, Inc. quarterly FCF year-on-year change?

Over the past year, TRVI quarterly free cash flow has changed by -$1.39M (-15.96%)

What is Trevi Therapeutics, Inc. TTM free cash flow?

The current TTM FCF of TRVI is -$42.69M

What is the all time high TTM FCF for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high TTM free cash flow is -$5.62M

What is Trevi Therapeutics, Inc. TTM FCF year-on-year change?

Over the past year, TRVI TTM free cash flow has changed by -$9.84M (-29.93%)
On this page